Revance Therapeutics, Inc.

MANUFACTURERS LIFE INSURANCE COMPANY, THE

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/14/2025

Shares

39,386

Value ($000)

120

Weight

0.0%

2019 Q4 - 2024 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/14/2025	120	0.0%	39,386	12/31/2024
2024 Q3	11/13/2024	211	0.0%	40,685	9/30/2024
2024 Q2	8/14/2024	109	0.0%	42,296	6/30/2024
2024 Q1	5/14/2024	161	0.0%	32,695	3/31/2024
2023 Q4	2/13/2024	354	0.0%	40,220	12/31/2023
2023 Q3	11/15/2023	477	0.0%	41,572	9/30/2023
2023 Q2	8/11/2023	843	0.0%	33,312	6/30/2023
2023 Q1	5/15/2023	1,020	0.0%	31,677	3/31/2023
2022 Q4	8/11/2023	565	0.0%	30,598	12/31/2022
2022 Q3	8/11/2023	741	0.0%	27,437	9/30/2022
2022 Q2	8/11/2023	386	0.0%	27,930	6/30/2022
2022 Q1	8/11/2023	567	0.0%	29,063	3/31/2022
2021 Q4	2/16/2022	603	0.0%	36,979	12/31/2021
2021 Q3	11/12/2021	1,016	0.0%	36,468	9/30/2021
2021 Q2	8/12/2021	1,170	0.0%	39,475	6/30/2021
2021 Q1	5/3/2021	1,001	0.0%	35,804	3/31/2021
2020 Q4	2/12/2021	1,072	0.0%	37,833	12/31/2020
2020 Q3	11/9/2020	894	0.0%	35,558	9/30/2020
2020 Q2	8/10/2020	862	0.0%	33,706	6/30/2020
2020 Q1	5/15/2020	461	0.0%	31,123	3/31/2020
2019 Q4	2/14/2020	433	0.0%	26,660	12/31/2019